$GH
BULLISH2025-10-29Price around the call
↑ 2025-10-29
By horizon✓ hit+13.8%
1d
…
5d
✓ +5.6%
21d
✓ +13.8%
Original post
Emmet Savage · 2025-10-29
Guardant Health $GH Q3 earnings: • Revenue up 39% YoY to $265M • Raised 2025 guidance to $965–$970M (+31%) • Oncology tests +40%, Screening revenue up from $1M → $24M! • Gross margin 66% (vs 63%) Shield multi-cancer test launch, FDA submission for Guardant360, & new Quest + ACS partnerships. I mean, come on. That’s pretty good. Shares up 16% after hours as I type.
View on X ↗